Anika Announces Data Presentation and Symposium on CINGAL at 2017 EFORT Annual Congress

anika therapeutics, inc. , a global, integrated orthopedics medicines company specializing in therapeutics based on its proprietary hyaluronic acid technology, today announced plans to present phase iii data on cingal®, its novel ha-corticosteroid combination viscosupplement, at the 2017 european federation of national associations of orthopedics and traumatology annual congress.

From:  finance.yahoo.com

Add Comment

Cancel

Not comments yet.

More
About author
Posts
0
Answers
0
Follows
0

About Privacy Terms faq

@2017 CareerAnswers